Ahaha Cynata aren't evaluating the data here, chief. Your company failed the trial, might be time to move on from the $2.5B company that doesn't have a saleable product.
Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-93
-
- There are more pages in this discussion • 930 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.055(5.16%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.04 | $1.00 | $2.096M | 2.059M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 138918 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 32131 | 12 |
View Market Depth
| Last trade - 12.27pm 04/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |